Clinical Trials
3 trialsNCT06646666 2024-11-01
ARTA-based Chemo-free Bridging/Maintenance Therapy in CAR-T Treatment for High-Risk R/R B-NHL Ineligible for HDCT and ASCT
Ruijin Hospital
Phase 2 Not yet recruiting
NCT00210314 2015-03-30
Phase II Trial of Combined Modality Treatment in Primary Central Nervous System Lymphoma
International Extranodal Lymphoma Study Group (IELSG)
Phase 2 Completed
NCT00210379 2009-07-22
Phase II Study of Combined Modality Treatment in Primary Testicular Non-Hodgkin's Lymphoma
International Extranodal Lymphoma Study Group (IELSG)
Phase 2 Completed